Using heat and magnets to clear harmful proteins in the brain for Alzheimer's treatment
Magnetothermal brain stimulation towards the rescue of beta-amyloid pathology
This study is exploring a new way to help people with Alzheimer's by using a special magnetic treatment to safely remove harmful proteins from the brain, which could improve thinking skills and make daily life better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kent State University NIH-funded |
| Lab location | 1 site (Kent, United States) |
| Project ID | NIH-11094836 on NIH RePORTER |
What this research studies
This research investigates a new method to treat Alzheimer's disease by using magnetothermal brain stimulation to target and remove toxic beta-amyloid plaques in the brain. The approach involves applying a high-frequency alternating magnetic field to superparamagnetic nanoparticles, which convert the magnetic energy into heat, helping to clear these harmful proteins. This minimally invasive technique aims to improve cognitive function and slow the progression of Alzheimer's disease. Patients may benefit from a non-drug intervention that could potentially enhance their quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who are experiencing cognitive deficits related to beta-amyloid plaque accumulation.
Not a fit: Patients with early-stage Alzheimer's disease or those without significant beta-amyloid plaque burden may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel, non-pharmacological treatment option for Alzheimer's disease that helps clear toxic proteins and improve cognitive function.
How similar studies have performed: While the approach of using magnetothermal stimulation is innovative, similar techniques targeting amyloid clearance have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
Kent, United States
- Kent State University — Kent, United States (Active)
Researchers
- Principal investigator: Kim, Min Ho — Kent State University
- Study coordinator: Kim, Min Ho
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.